首页> 外文会议>European Congress of Immunology >T-lymphocyte changes during intestinal tumorsgenesis in the ApcMin/+ mouse model
【24h】

T-lymphocyte changes during intestinal tumorsgenesis in the ApcMin/+ mouse model

机译:T淋巴细胞在APCMIN / +小鼠模型中的肠道瘤中发生变化

获取原文

摘要

Cox-2 promotes intestinal adenoma development and induces a regulatory T-cell phenotype. Adoptive transfer of regulatory T-cells has been shown to down-regulate intestinal Cox-2 expression and lead to regression of intestinal adenomas in the Apc-~(Min/+) mice mouse model of FAR Therefore, we studied the intestinal and inguinal lymphocyte populations in Apc~(Min/+) mice and wild-type littermates. While significantly increased numbers of CD25-expressing cells were observed among Apc~(Min/+) intestinal and inguinal lymphocytes, increased numbers of Foxp3-expressing cells were found among Apc~(Min/+) intestinal but not inguinal lymphocytes. The immunological mechanism polarizing towards a regulatory T-cell phenotype by means of increased intestinal Cox-2 expression in the Apc~(Min/+) mouse merits further evaluation as a therapeutic target in prevention of intestinal tumorigenesis.
机译:COX-2促进肠腺瘤发育并诱导调节性T细胞表型。已经证明了监管T细胞的养分转移到下调肠道COX-2表达,并导致肠道腺瘤的回归在APC-〜(min / +)小鼠模型中,我们研究了肠道和腹股沟淋巴细胞APC〜(min / +)小鼠和野生型凋落物中的种群。虽然在APC〜(min / +)肠道和腹股沟淋巴细胞中观察到显着增加CD2M表达细胞数量,但在APC〜(MIN / +)肠道中没有增加FOXP3表达细胞的数量,但不是腹股沟淋巴细胞。通过APC〜(MIN / +)小鼠中的增加的肠COX-2表达,通过增加的肠COX-2表达偏振的免疫机制偏离调节性T细胞表型,作为预防肠道肿瘤瘤的治疗靶标进一步评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号